Literature DB >> 8384245

Characterization of two cytosolic diacylglycerol kinase forms.

Q Chen1, N Klemm, I Jeng.   

Abstract

Two forms of rat brain cytosolic diacylglycerol kinase (EC2.7.1.107) were separated by heparin-agarose column chromatography. These forms, designated DGK-I and DGK-II, were not interconvertible as determined by rechromatography. DGK-I and DGK-II had respective molecular masses of 88 and 180 kDa, as measured by Sepharose 6B chromatography. Both forms preferred diacylglycerol over monoacylglycerol and were insensitive to R59022. DGK-II, but not DGK-I, was activated by an activator substance prepared from chicken egg yolk. DGK-II was activated by a rat brain cytosolic activator and was exclusively sensitive to 5'-AMP-mediated inactivation. Further studies revealed that these two forms had the following distinct characteristics: (a) substrate specificity, (b) inhibition by heparin, (c) sensitivity to lysine-containing polyamino acids, and (d) responses to different phospholipids. In general, DGK-II was more responsive to various inhibitors and activators, making it a prime candidate for a regulatable enzyme.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8384245     DOI: 10.1111/j.1471-4159.1993.tb03279.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  3 in total

1.  Purification and characterization of sn-1-stearoyl-2-arachidonoylglycerol kinase from pig testes.

Authors:  M N Hodgkin; S D Gardner; S Rose; A Paterson; A Martin; M J Wakelam
Journal:  Biochem J       Date:  1997-03-01       Impact factor: 3.857

2.  Phosphorylation of lipids in rat primary glial cells and immortalized astrocytes (DITNC).

Authors:  W Tong; G Y Sun
Journal:  Lipids       Date:  1994-06       Impact factor: 1.880

3.  Bacterial expression strategies for several Sus scrofa diacylglycerol kinase alpha constructs: solubility challenges.

Authors:  Elizabeth J Petro; Daniel M Raben
Journal:  Sci Rep       Date:  2013       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.